Follow us on:

AZN

AstraZeneca’s Lynparza receives EU approval for pancreatic cancer

July 8, 2020

AstraZeneca’s selumetinib granted orphan drug designation in Japan

June 30, 2020

AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s COVID-19 vaccine

June 15, 2020

AstraZeneca Brilinta approved in the US by FDA

June 1, 2020

AstraZeneca Tagrisso demonstrates unprecedented disease-free survival

May 29, 2020

AstraZeneca Enhertu granted Orphan Drug Designation in the US for gastric cancer

May 22, 2020

AstraZeneca concludes first agreements for University of Oxford’s potential new COVID-19 vaccine

May 21, 2020

AstraZeneca Lynparza approved in the US by FDA for prostate cancer

May 20, 2020

AstraZeneca’s Bevespi Aerosphere approved in China for patients with COPD

May 18, 2020

AstraZeneca Enhertu granted Breakthrough Therapy Designation in the US

May 11, 2020

AstraZeneca Farxiga approved in the US for the treatment of heart failure

May 6, 2020

AstraZeneca’s Lynparza demonstrates overall survival benefit in prostate cancer

April 24, 2020

AstraZeneca unblind Phase III ADAURA trial much earlier than expected

April 14, 2020

AstraZeneca Imfinzi approved in the US for extensive-stage small cell lung cancer

March 30, 2020

AstraZeneca Lokelma approved in Japan for the treatment of patients with hyperkalaemia

March 26, 2020

AstraZeneca Lynparza granted orphan drug designation in Japan

March 19, 2020

AstraZeneca Imfinzi confirmed overall survival in Phase III CASPIAN trial

March 17, 2020

AstraZeneca Phase III GY004 trial did not meet the primary endpoint

March 12, 2020

AstraZeneca Phase III DANUBE did not meet the primary endpoints

March 6, 2020

AstraZeneca completes divestment agreement with Atnahs Pharma

March 2, 2020

News and Interview Alerts

Company Presentations

Randall & Quilter

Randall & Quilter Chairman’s overview – rising profitability, growth catalysts, dividends and five year plan

Falanx Group

Falanx Assynt – A Company Overview

Immotion Group

Immotion Group the exciting world of VR Location and Home Based Entertainment (Interview)

Symphony Environmental Technologies

Symphony Environmental Technologies 2020 Results Presentation

Q&As

Hardman & Co

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Chesnara Plc: Showing good operational progress

8 September 2025

Arbuthnot Banking Group 1H’25 results: Growing where it wants to

30 July 2025

ICG Enterprise Trust Investor Seminar 2025: Resilience and Growth

2 July 2025

Green News

Ilika plc Stereax Micro Batteries Enter Production with Customer Deliveries on the Horizon (Video)

18 August 2025

Drax Group

Drax Group appoints former Shell Executive Frank Lemmink as CFO

1 July 2025

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

Apax Global Alpha Why 2025 Could Unlock a Wave of Value for Investors (Video)

Diverse Income Trust Gervais Williams More Bullish on Small Caps Than He’s Been in 30 Years (Video)

H&T Group Interview

H&T Group 5 Growth Drivers Powering the UK’s Largest Pawnbroker (Video)

BrokerTalk

Jubilee Metals

Jubilee Metals Ramps Up Chrome and PGM Output – Zeus Capital

17 April 2025

SDI Group acquires Collins Walker

SDI Group Powers Into Electric Boiler Market With Smart Acquisition – Cavendish

7 April 2025

Quadrise plc

Quadrise Signs Key Agreement as MSC Trial Nears – Shore Capital

3 April 2025

Pharos Energy

Pharos Energy positioned for 2025 growth following solid 2024 performance

2 April 2025

Funds

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

View all Funds, Market Insights and news >>

FTSE 100 News

UK Broker Ratings

Exploring Syncona Limited (SYNC.L): A Glimpse Into the Life Sciences Investment Giant

18 September 2025

Spirent Communications plc (SPT.L): Navigating the Tech Landscape with Cautionary Valuations

18 September 2025

Serco Group PLC (SRP.L): Navigating Growth in Specialty Business Services with Promising Upside Potential

18 September 2025

Supermarket Income REIT plc (SUPR.L): A Strategic Look at Its Market Position and Future Potential

18 September 2025

SSP GROUP PLC (SSPG.L): Navigating Opportunities Amidst Economic Cycles

18 September 2025

AZN

AstraZeneca’s Lynparza receives EU approval for pancreatic cancer

July 8, 2020

AstraZeneca’s selumetinib granted orphan drug designation in Japan

June 30, 2020

AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s COVID-19 vaccine

June 15, 2020

AstraZeneca Brilinta approved in the US by FDA

June 1, 2020

AstraZeneca Tagrisso demonstrates unprecedented disease-free survival

May 29, 2020

AstraZeneca Enhertu granted Orphan Drug Designation in the US for gastric cancer

May 22, 2020

AstraZeneca concludes first agreements for University of Oxford’s potential new COVID-19 vaccine

May 21, 2020

AstraZeneca Lynparza approved in the US by FDA for prostate cancer

May 20, 2020

AstraZeneca’s Bevespi Aerosphere approved in China for patients with COPD

May 18, 2020

AstraZeneca Enhertu granted Breakthrough Therapy Designation in the US

May 11, 2020

AstraZeneca Farxiga approved in the US for the treatment of heart failure

May 6, 2020

AstraZeneca’s Lynparza demonstrates overall survival benefit in prostate cancer

April 24, 2020

AstraZeneca unblind Phase III ADAURA trial much earlier than expected

April 14, 2020

AstraZeneca Imfinzi approved in the US for extensive-stage small cell lung cancer

March 30, 2020

AstraZeneca Lokelma approved in Japan for the treatment of patients with hyperkalaemia

March 26, 2020

AstraZeneca Lynparza granted orphan drug designation in Japan

March 19, 2020

AstraZeneca Imfinzi confirmed overall survival in Phase III CASPIAN trial

March 17, 2020

AstraZeneca Phase III GY004 trial did not meet the primary endpoint

March 12, 2020

AstraZeneca Phase III DANUBE did not meet the primary endpoints

March 6, 2020

AstraZeneca completes divestment agreement with Atnahs Pharma

March 2, 2020

News and Interview Alerts

Company Presentations

Randall & Quilter

Randall & Quilter Chairman’s overview – rising profitability, growth catalysts, dividends and five year plan

Falanx Group

Falanx Assynt – A Company Overview

Immotion Group

Immotion Group the exciting world of VR Location and Home Based Entertainment (Interview)

Symphony Environmental Technologies

Symphony Environmental Technologies 2020 Results Presentation

Q&As

Hardman & Co

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Chesnara Plc: Showing good operational progress

8 September 2025

Arbuthnot Banking Group 1H’25 results: Growing where it wants to

30 July 2025

ICG Enterprise Trust Investor Seminar 2025: Resilience and Growth

2 July 2025

Green News

Ilika plc Stereax Micro Batteries Enter Production with Customer Deliveries on the Horizon (Video)

18 August 2025

Drax Group

Drax Group appoints former Shell Executive Frank Lemmink as CFO

1 July 2025

View all Sustainable sectors, Plcs and news >>

Search

Latest interviews

Apax Global Alpha Why 2025 Could Unlock a Wave of Value for Investors (Video)

Diverse Income Trust Gervais Williams More Bullish on Small Caps Than He’s Been in 30 Years (Video)

H&T Group Interview

H&T Group 5 Growth Drivers Powering the UK’s Largest Pawnbroker (Video)

Broker Talk

Jubilee Metals

Jubilee Metals Ramps Up Chrome and PGM Output – Zeus Capital

17 April 2025

SDI Group acquires Collins Walker

SDI Group Powers Into Electric Boiler Market With Smart Acquisition – Cavendish

7 April 2025

Quadrise plc

Quadrise Signs Key Agreement as MSC Trial Nears – Shore Capital

3 April 2025

Pharos Energy

Pharos Energy positioned for 2025 growth following solid 2024 performance

2 April 2025

Funds

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

View all Funds, Market Insights and news >>

FTSE 100 News

UK Broker Ratings

Exploring Syncona Limited (SYNC.L): A Glimpse Into the Life Sciences Investment Giant

18 September 2025

Spirent Communications plc (SPT.L): Navigating the Tech Landscape with Cautionary Valuations

18 September 2025

Serco Group PLC (SRP.L): Navigating Growth in Specialty Business Services with Promising Upside Potential

18 September 2025

Supermarket Income REIT plc (SUPR.L): A Strategic Look at Its Market Position and Future Potential

18 September 2025

SSP GROUP PLC (SSPG.L): Navigating Opportunities Amidst Economic Cycles

18 September 2025

AZN

AstraZeneca

AstraZeneca’s Lynparza receives EU approval for pancreatic cancer

8 July 2020

AstraZeneca

AstraZeneca’s selumetinib granted orphan drug designation in Japan

30 June 2020

coronavirus vaccine

AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s COVID-19 vaccine

15 June 2020

biopharmaceutical

AstraZeneca Brilinta approved in the US by FDA

1 June 2020

AstraZeneca

AstraZeneca Tagrisso demonstrates unprecedented disease-free survival

29 May 2020

biopharmaceutical

AstraZeneca Enhertu granted Orphan Drug Designation in the US for gastric cancer

22 May 2020

coronavirus vaccine

AstraZeneca concludes first agreements for University of Oxford’s potential new COVID-19 vaccine

21 May 2020

AstraZeneca

AstraZeneca Lynparza approved in the US by FDA for prostate cancer

20 May 2020

chronic obstructive pulmonary disease

AstraZeneca’s Bevespi Aerosphere approved in China for patients with COPD

18 May 2020

intravenous (IV) line

AstraZeneca Enhertu granted Breakthrough Therapy Designation in the US

11 May 2020

AstraZeneca

AstraZeneca Farxiga approved in the US for the treatment of heart failure

6 May 2020

AstraZeneca

AstraZeneca’s Lynparza demonstrates overall survival benefit in prostate cancer

24 April 2020

AstraZeneca

AstraZeneca unblind Phase III ADAURA trial much earlier than expected

14 April 2020

antibody

AstraZeneca Imfinzi approved in the US for extensive-stage small cell lung cancer

30 March 2020

Drug production

AstraZeneca Lokelma approved in Japan for the treatment of patients with hyperkalaemia

26 March 2020

biopharmaceutical

AstraZeneca Lynparza granted orphan drug designation in Japan

19 March 2020

biopharmaceutical

AstraZeneca Imfinzi confirmed overall survival in Phase III CASPIAN trial

17 March 2020

oncology

AstraZeneca Phase III GY004 trial did not meet the primary endpoint

12 March 2020

pharma

AstraZeneca Phase III DANUBE did not meet the primary endpoints

6 March 2020

Heart health

AstraZeneca completes divestment agreement with Atnahs Pharma

2 March 2020

Latest Interviews

Apax Global Alpha Why 2025 Could Unlock a Wave of Value for Investors (Video)

17 April 2025

Diverse Income Trust Gervais Williams More Bullish on Small Caps Than He’s Been in 30 Years (Video)

9 April 2025

H&T Group Interview

H&T Group 5 Growth Drivers Powering the UK’s Largest Pawnbroker (Video)

7 April 2025

FTSE 100 News

FTSE 250 News

News and Interview Alerts

Company Presentations

Randall & Quilter

Randall & Quilter Chairman’s overview – rising profitability, growth catalysts, dividends and five year plan

14 July 2021

Falanx Group

Falanx Assynt – A Company Overview

14 June 2021

Immotion Group

Immotion Group the exciting world of VR Location and Home Based Entertainment (Interview)

7 June 2021

Symphony Environmental Technologies

Symphony Environmental Technologies 2020 Results Presentation

24 May 2021

Q&As

Hardman & Co

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Chesnara Plc: Showing good operational progress

8 September 2025

Arbuthnot Banking Group 1H’25 results: Growing where it wants to

30 July 2025

ICG Enterprise Trust Investor Seminar 2025: Resilience and Growth

2 July 2025

BrokerTalk

Jubilee Metals

Jubilee Metals Ramps Up Chrome and PGM Output – Zeus Capital

17 April 2025

SDI Group acquires Collins Walker

SDI Group Powers Into Electric Boiler Market With Smart Acquisition – Cavendish

7 April 2025

Quadrise plc

Quadrise Signs Key Agreement as MSC Trial Nears – Shore Capital

3 April 2025

Pharos Energy

Pharos Energy positioned for 2025 growth following solid 2024 performance

2 April 2025

FTSE 100

Funds

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

View all Funds, Market Insights and news >>

Green News

Ilika plc Stereax Micro Batteries Enter Production with Customer Deliveries on the Horizon (Video)

18 August 2025

Drax Group

Drax Group appoints former Shell Executive Frank Lemmink as CFO

1 July 2025

View all Sustainable sectors, Plcs and news >>

UK Broker Ratings

Exploring Syncona Limited (SYNC.L): A Glimpse Into the Life Sciences Investment Giant

18 September 2025

Spirent Communications plc (SPT.L): Navigating the Tech Landscape with Cautionary Valuations

18 September 2025

Serco Group PLC (SRP.L): Navigating Growth in Specialty Business Services with Promising Upside Potential

18 September 2025

Supermarket Income REIT plc (SUPR.L): A Strategic Look at Its Market Position and Future Potential

18 September 2025

SSP GROUP PLC (SSPG.L): Navigating Opportunities Amidst Economic Cycles

18 September 2025